<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genet Mol Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Genet. Mol. Biol</journal-id>
<journal-id journal-id-type="publisher-id">gmb</journal-id>
<journal-title-group>
<journal-title>Genetics and Molecular Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1415-4757</issn>
<issn pub-type="epub">1678-4685</issn>
<publisher>
<publisher-name>Sociedade Brasileira de Genética</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31271591</article-id>
<article-id pub-id-type="pmc">6726149</article-id>
<article-id pub-id-type="doi">10.1590/1678-4685-GMB-2017-0354</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Human and Medical Genetics</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Association of S100B polymorphisms and serum S100B with risk of
systemic lupus erythematous in a Chinese population</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Yulan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c2">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Huatuo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c2">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Chunhong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c2">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zeng</surname>
<given-names>Yonglong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Rong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Chunfang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-3878-6304</contrib-id>
<name>
<surname>Wei</surname>
<given-names>Yesheng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lan</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1">
<label> 1 </label>Department of Clinical Laboratory, Affiliated Hospital of
Youjiang Medical University for Nationalities, No.18 Zhongshan Road II, Baise
533000, Guangxi, China</aff>
<aff id="aff2">
<label> 2 </label>Department of Dermatology, Affiliated Hospital of Youjiang
Medical University for Nationalities, Guangxi, China</aff>
</contrib-group>
<author-notes>
<corresp id="c1">Send correspondence to Yesheng Wei. Department of Clinical
Laboratory, Affiliated Hospital of Youjiang Medical University for
Nationalities, No.18 Zhongshan Road II, Baise 533000, Guangxi, China. E-mail:
<email>yeshengwei88@163.com</email></corresp>
<corresp id="c2"><sup>*</sup>These authors equally contributed to this work.</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<season>Apr-Jun</season>
<year>2019</year>
</pub-date>
<volume>42</volume>
<issue>2</issue>
<fpage>321</fpage>
<lpage>328</lpage>
<history>
<date date-type="received">
<day>17</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019, Sociedade Brasileira de
Genética.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>License information: This is an open-access article distributed under
the terms of the Creative Commons Attribution License (type CC-BY), which
permits unrestricted use, distribution and reproduction in any medium,
provided the original article is properly cited.</license-p>
</license>
</permissions>
<abstract>
<title>Abstract</title>
<p>The aim of this study was to investigate whether the S100B polymorphisms are
associated with systemic lupus erythematous (SLE) in a Chinese population. A
total of 313 SLE patients and 396 control subjects were enrolled in the present
study. The genotypes of three SNPs (rs9722, rs881827 and rs1051169) in S100B
gene were detected by single base extension polymerase chain reaction (SBE-PCR).
Serum S100B levels were determined by enzyme-linked immunosorbent assay (ELISA).
Rs1051169 was associated with an increased risk of SLE (C vs. G: adjusted
OR=1.46, 95% CI, 1.18-1.80, <italic>p</italic>=0.001; CC vs. GG: adjusted
OR=1.99, 95% CI, 1.32-3.02, <italic>p</italic>=0.001; CC+GC vs. GG: adjusted
OR=1.54, 95% CI, 1.13-2.11, <italic>p</italic>=0.007; CC vs. GC+GG: adjusted
OR=1.67, 95% CI, 1.16-2.42, <italic>p</italic>=0.006). Haplotype analysis showed
that the G-G-C haplotype was associated with an increased risk of SLE (OR=1.50,
95% CI, 1.14-1.98, <italic>p</italic>=0.004). Stratified analyses showed that
the rs1051169 polymorphism was associated with an increased risk of neurologic
disorder in SLE patients (C vs. G: OR=1.78, 95% CI, 1.22-2.59,
<italic>p</italic>=0.003; GC vs. GG: OR=2.33, 95% CI, 1.14-4.77, P=0.019; CC
vs. GG: OR=3.02, 95% CI, 1.39-6.53, <italic>p</italic>=0.004; CC+GC vs. GG:
OR=2.57, 95% CI=1.31-5.04, <italic>p</italic>=0.005). In addition, SLE patients
with neurologic disorder carrying the rs1051169 GC/CC genotypes present a higher
serum S100B levels compared with that carrying the GG genotype
(<italic>p</italic> &lt; 0.05). Our results indicate that the rs1051169
polymorphism may be involved in the pathogenesis of SLE.</p>
</abstract>
<kwd-group>
<title>Keywords:</title>
<kwd>S100B</kwd>
<kwd>polymorphisms</kwd>
<kwd>serum levels</kwd>
<kwd>SLE</kwd>
<kwd>neurologic disorder</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="5"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="45"></ref-count>
<page-count count="8"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Systemic lupus erythematous (SLE) is a common systemic autoimmune disease
characterized by autoantibody production and immune complex deposition, resulting in
damage to multiple tissues and organs, as well as physiological function impairment
(<xref ref-type="bibr" rid="B2">Aringer, <italic>et al.</italic>, 2016</xref>).
Most of the SLE patients will develop various symptoms, such as malar rash,
arthritis, nephritis, and neurologic disorders (<xref ref-type="bibr" rid="B36">Wada, <italic>et al.</italic>, 2017</xref>). In China, the prevalence of SLE is
0.03% and it has come to be a heavy burden on family and society (<xref ref-type="bibr" rid="B22">Li, <italic>et al.</italic>, 2012</xref>; <xref ref-type="bibr" rid="B18">Holloway, <italic>et al.</italic>, 2014</xref>). It
represents a primary challenge to health care and is considered as a major Chinese
health concern. Yet to date, the exact pathogenic mechanism of SLE has not been
fully elucidated. Several risk factors have been identified to contribute to the
pathogenesis of SLE, such as genetic, environmental, infection, and hormonal
factors. Among the well-known predisposing factors, genetic factors seem to play a
key role in the susceptibility (<xref ref-type="bibr" rid="B1">Alarcon-Segovia,
<italic>et al.</italic>, 2005</xref>; <xref ref-type="bibr" rid="B33">Tiffin, <italic>et al.</italic>, 2013</xref>; <xref ref-type="bibr" rid="B34">Ulff-Moller, <italic>et al.</italic>, 2017</xref>).</p>
<p>As is known, many cytokines are involved in the pathogenesis of autoimmune diseases.
S100B is a member of the S100 family and primarily secreted by astrocytes, but to a
lesser extent it is also produced by other cell types, such as dendritic cell,
macrophages, monocytes, and T cells (<xref ref-type="bibr" rid="B9">Donato,
<italic>et al.</italic>, 2009</xref>, <xref ref-type="bibr" rid="B10">2013</xref>; <xref ref-type="bibr" rid="B25">Miki, <italic>et al.</italic>,
2013</xref>). S100B is thought to have intracellular and extracellular roles in
the regulation of many diverse processes, such as cell growth and motility,
cell-cycle regulation, transcription, differentiation, and Ca<sup>2+</sup>
homeostasis (<xref ref-type="bibr" rid="B42">Yardan, <italic>et al.</italic>,
2011</xref>). In addition, S100B has been viewed as a damage-associated
molecular pattern (DAMP) involved in the inflammatory response, and serves as a
generic receptor for the advanced glycation end products (RAGE) activator in the
context of the inflammatory response (<xref ref-type="bibr" rid="B39">Xiao,
<italic>et al.</italic>, 2014</xref>; <xref ref-type="bibr" rid="B35">Uspenskaya, <italic>et al.</italic>, 2015</xref>; <xref ref-type="bibr" rid="B6">Cao, <italic>et al.</italic>, 2017</xref>). Increasing evidence has
shown that S100B binding to RAGE can promote the release of inflammatory cytokines
via the activation of NF-κB, JNK, PI3K ,and P38 MAPK (<xref ref-type="bibr" rid="B4">Bianchi, <italic>et al.</italic>, 2010</xref>, <xref ref-type="bibr" rid="B5">2011</xref>). These signaling pathways were known to be involved in the
regulation of SLE (<xref ref-type="bibr" rid="B45">Zhi-Chun, <italic>et
al.</italic>, 2012</xref>; <xref ref-type="bibr" rid="B29">Shi, <italic>et
al.</italic>, 2015</xref>). In addition, substantial evidence has showed
that S100B is associated with pathological injury or clinical severity in a variety
of autoimmune disease (<xref ref-type="bibr" rid="B38">Wang, <italic>et
al.</italic>, 2013</xref>; <xref ref-type="bibr" rid="B13">Gomez-Tourino,
<italic>et al.</italic>, 2015</xref>; <xref ref-type="bibr" rid="B20">Lapa,
<italic>et al.</italic>, 2017</xref>). Within this context, we hypothesized
that S100B might be involved in the development of SLE.</p>
<p>The gene encoding S100B is located on chromosome 21q22.2-q22.3 and consists of three
exons and two introns. Recently, genetic association studies have indicated that
S100B polymorphisms are related to human diseases, such as invasive aspergillosis,
autism spectrum disorder, bipolar affectivedisorder, and dyslexia (<xref ref-type="bibr" rid="B27">Roche, <italic>et al.</italic>, 2007</xref>; <xref ref-type="bibr" rid="B11">Egger, <italic>et al.</italic>, 2014</xref>; <xref ref-type="bibr" rid="B24">Matsson, <italic>et al.</italic>, 2015</xref>; <xref ref-type="bibr" rid="B8">Dix, <italic>et al.</italic>, 2016</xref>). In
addition, genetic variants in the S100B gene have been reported as significantly
associated with the higher expression of S100B (<xref ref-type="bibr" rid="B23">Liu,
<italic>et al.</italic>, 2005</xref>; <xref ref-type="bibr" rid="B17">Hohoff, <italic>et al.</italic>, 2010</xref>). Given the important roles that
the abnormal expression of S100B plays in the development of autoimmune and
inflammatory diseases (<xref ref-type="bibr" rid="B16">Hofmann, <italic>et
al.</italic>, 1999</xref>; <xref ref-type="bibr" rid="B19">Hwang, <italic>et
al.</italic>, 2011</xref>; <xref ref-type="bibr" rid="B3">Bechmann,
<italic>et al.</italic>, 2013</xref>; <xref ref-type="bibr" rid="B13">Gomez-Tourino, <italic>et al.</italic>, 2015</xref>), we hypothesized that SNPs
in the S100B gene may influence the expression of S100B and ultimately be involved
in the etiology of SLE. To test this hypothesis, we selected three SNPs (rs9722,
rs881827 and rs1051169) in the S100B gene and performed a case-control study to
investigate the association of these SNPs with susceptibility to SLE in a Chinese
population.</p>
</sec>
<sec sec-type="materials">
<title>Material and Methods</title>
<sec>
<title>Subjects</title>
<p>A total of 313 SLE patients (63 men and 250 women, average age 38.05 ± 12.93
years) were recruited from the Department of Dermatology, Affiliated Hospital of
Youjiang Medical University for Nationalities, Guangxi, China between January
2013 and September 2016. The diagnosis of SLE was based on the 1997 revised
American College of Rheumatology (ACR) SLE criteria (<xref ref-type="bibr" rid="B15">Hochberg, 1997</xref>). Their medical records were reviewed with
particular attention to neuropsychiatric manifestations, which were ascertained
by relevant specialists, employing laboratory and imaging investigations and
were objectively documented. The 396 controls (98 men and 298 women, average age
39.48 ± 12.10 years) were matched to the patients on the basis of age and
gender, and they were recruited from Health Medical Center of the hospital
during the same period. According to the thorough clinical and laboratory
evaluation, none of them was found to have any history of autoimmune disorders.
Data about demographic and clinical features were collected from hospital
records or by questionnaire, and were reviewed by experienced physicians.
Written informed consent was obtained from all participants, and this study was
approved by the research ethics committee of our hospital.</p>
</sec>
<sec>
<title>DNA extraction</title>
<p>Blood samples from all subjects were collected in EDTA-containing tubes. Genomic
DNA was isolated from peripheral blood mononuclear cells using a DNA extraction
kit (QIAGEN, China) according to the manufacturer’s instructions and then stored
at -70 °C for later use.</p>
</sec>
<sec>
<title>Determination of S100B genotype</title>
<p>Primer probes were designed using Primer Express Software (version 3.0) and
synthesized by Applied Biosystems (Foster City, CA). The primers used were as
follows: rs9722: ACAACACGGCTGGAAAGCTCAG (forward), GATGGAGACG GCGAATGTGACT
(reverse), TTTTTTTTTTTTTTTTTTGCCAAACCTTTCCTGTAA CAGAGA (extended); rs881827:
TGTGTGTGGAAGTC CCTGTCTCA (forward), CCCTGCACTGTGGTTGTTC CTC (reverse),
TTTTTTTTTTTTTTTTTTTTTTTTTTT TGTTGCTGAAGTAACTCTTGGGAAC(extended); rs1051169:
TCACCTTCA GGGCAGCTGAGAA (forward), TGGAAGGGAGGGAGACAAGCAC(reverse),
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT TCACAAGCTGAAGAAATCCGAACT(extended). SNP
genotyping was performed by SBE-PCR. Amplifications were performed in a total
volume of 20 μL, comprised of 3.0 mmol/L Mg<sup>2+</sup>, 0.3 mmol/L dNTP, 1 U
HotStar<italic>Taq</italic> polymerase, 1 μL genomic DNA, 1 μL PCR primer
and 1x GC-I buffer (Takara, Japan). The PCR conditions included an initial
denaturation step at 94 °C for 20 s, followed by 35 cycles with 20 s of
denaturation at 94 °C, 30 s of annealing at 59 °Cm and 1.5 min of elongation at
72 °C, followed by a final elongation step of 72 °C for 2 min. PCR products were
digested with shrimp enzyme (Promega, Madison, WI) and excision enzyme
(Epicentre, Madison WI). An ABI PRISM 3730XL analyzer (Applied Biosystems) was
used to sequence the PCR products, and GeneMapper4.1 was used to analyze the
sequencing data. The samples were reanalyzed and verified by DNA sequencing when
conflicting results occurred. In addition, approximately 10% of all samples were
randomly selected to be confirmed by DNA sequencing, and the results were 100%
consistent.</p>
</sec>
<sec>
<title>Serum S100B determination</title>
<p>Serum samples from SLE patients and controls were separated from peripheral
venous blood at room temperature and stored at -70°C until use. The quantity
determination of serum S100B were performed by ELISA kits (No: RD192090100R,
BioVendor-Laboratorní medicína) following the manufacturer’s protocol. The
concentration of serum S100B was determined using a standard curve constructed
with the kit’s standards over the range of 10-320 pg/mL.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>All data were analyzed by the SPSS software version 17.0 (SPSS, Inc, Chicago, IL,
USA). Hardy-Weinberg equilibrium (HWE) was tested by the chi-square test.
Demographic and clinical data between groups were compared by chi-square test or
Student’s <italic>t</italic>-test. Logistic regression was used to estimate odds
ratio (OR) and 95% confidence interval (95% CI). False discovery rate (FDR)
approach was used to correct for multiple testing. In brief, the stringent
<italic>p</italic>-value was considered statistically significant if it was
less than 0.05. The haplotype analysis was performed by online SHEsis software
(<xref ref-type="bibr" rid="B30">Shi and He, 2005</xref>), and
<italic>p</italic> &lt; 0.05 was considered to be statistically
significant.</p>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Clinical characteristics of the study participants</title>
<p>A total of 313 SLE patients and 396 control subjects were included in this study.
The clinical characteristics of the study participants are listed in <xref ref-type="table" rid="t1">Table 1</xref>. There were no significant
differences in age and gender distribution between the case and control groups
(<italic>p</italic> &gt; 0.05).</p>
<table-wrap id="t1" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<title>Clinical characteristics of the subjects.</title>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1" width="25%">
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr>
<th align="left" colspan="1" rowspan="1">Characteristics</th>
<th align="center" colspan="1" rowspan="1">SLE patients (n=313)</th>
<th align="center" colspan="1" rowspan="1">Controls (n=396)</th>
<th align="center" colspan="1" rowspan="1">
<italic>p-</italic>value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age, year (mean ± SD)</td>
<td align="center" colspan="1" rowspan="1">38.05 ± 12.93</td>
<td align="center" colspan="1" rowspan="1">39.48 ± 12.10</td>
<td align="center" colspan="1" rowspan="1">0.131</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gender (M/F)</td>
<td align="center" colspan="1" rowspan="1">63/250</td>
<td align="center" colspan="1" rowspan="1">98/298</td>
<td align="center" colspan="1" rowspan="1">0.145</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cutaneous vasculitis (%)</td>
<td align="center" colspan="1" rowspan="1">146 (46.65)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Family history of SLE (%)</td>
<td align="center" colspan="1" rowspan="1">89 (28.43)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Arthritis (%)</td>
<td align="center" colspan="1" rowspan="1">139 (44.41)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pleuritis (%)</td>
<td align="center" colspan="1" rowspan="1">42 (13.42)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Malar rash (%)</td>
<td align="center" colspan="1" rowspan="1">93 (29.71)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Renal disorder (%)</td>
<td align="center" colspan="1" rowspan="1">161 (51.44)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Neurologic disorder (%)</td>
<td align="center" colspan="1" rowspan="1">71 (22.68)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-dsDNA antibody-positive (%)</td>
<td align="center" colspan="1" rowspan="1">153 (48.88)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-Sm-positive (%)</td>
<td align="center" colspan="1" rowspan="1">123 (39.30)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-RNP-positive (%)</td>
<td align="center" colspan="1" rowspan="1">135 (43.13)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ANA positive (%)</td>
<td align="center" colspan="1" rowspan="1">286 (91.37)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Low levels of C3 (%)</td>
<td align="center" colspan="1" rowspan="1">127 (40.57)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Low levels of C4 (%)</td>
<td align="center" colspan="1" rowspan="1">101 (32.27)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>SLE, systemic lupus erythematosus; Anti-dsDNA, double-stranded DNA
antibody; Anti-Sm, smith antibody; Anti-RNP, ribonucleoprotein antibody;
ANA, antinuclear antibody; C3, complement 3; C4, complement 4.</attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Association of S100B polymorphisms with SLE risk</title>
<p>The distributions of the S100B gene rs9722, rs881827 and rs1051169 in SLE
patients and controls are shown in <xref ref-type="table" rid="t2">Table
2</xref>. The genotype distribution of the three SNPs in the control group
was in agreement with HWE (both <italic>p</italic> &gt; 0.05). The minor C
allele of rs1051169, relative to the major G allele, appeared to have a
significantly increased risk of SLE (C vs. G: adjusted OR=1.46, 95% CI,
1.18-1.80, <italic>p</italic>=0.001). Similarly, a statistical significance was
also found for the rs1051169 CC genotype, dominant and recessive model (CC vs.
GG: adjusted OR=1.99, 95% CI, 1.32-3.02, <italic>p</italic>=0.001; CC+GC vs. GG:
adjusted OR=1.54, 95% CI, 1.13-2.11, <italic>p</italic>=0.007; CC vs. GC+GG:
adjusted OR=1.67, 95% CI, 1.16-2.42, <italic>p</italic>=0.006). The
<italic>p</italic>-values remained significant after correction for multiple
testing. However, no significant association between other SNPs (rs9722 and
rs881827) and SLE risk was observed (<italic>p</italic> &gt; 0.05).</p>
<table-wrap id="t2" orientation="portrait" position="float">
<label>Table 2</label>
<caption>
<title>Association between S100B polymorphisms and risk of SLE.</title>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1" width="16%">
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr>
<th align="left" colspan="1" rowspan="1">SNPs</th>
<th align="center" colspan="1" rowspan="1">Controls (n=396)</th>
<th align="center" colspan="1" rowspan="1">SLE(n=313)</th>
<th align="center" colspan="1" rowspan="1">Adjusted OR (95% CI)*</th>
<th align="center" colspan="1" rowspan="1">
<italic>P*</italic>
</th>
<th align="center" colspan="1" rowspan="1">
<italic>P</italic>
<sub><italic>BH</italic></sub>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">rs9722</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GG</td>
<td align="center" colspan="1" rowspan="1">182 (46.0)</td>
<td align="center" colspan="1" rowspan="1">154 (49.2)</td>
<td align="center" colspan="1" rowspan="1">1.0 (Ref)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GA</td>
<td align="center" colspan="1" rowspan="1">170 (42.9)</td>
<td align="center" colspan="1" rowspan="1">134 (42.8)</td>
<td align="center" colspan="1" rowspan="1">0.93 (0.68-1.27)</td>
<td align="center" colspan="1" rowspan="1">0.646</td>
<td align="center" colspan="1" rowspan="1">0.745</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AA</td>
<td align="center" colspan="1" rowspan="1">44 (11.1)</td>
<td align="center" colspan="1" rowspan="1">25 (8.0)</td>
<td align="center" colspan="1" rowspan="1">0.68 (0.40-1.16)</td>
<td align="center" colspan="1" rowspan="1">0.160</td>
<td align="center" colspan="1" rowspan="1">0.394</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="center" colspan="1" rowspan="1">534 (67.4)</td>
<td align="center" colspan="1" rowspan="1">442 (70.6)</td>
<td align="center" colspan="1" rowspan="1">1.0 (Ref)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="center" colspan="1" rowspan="1">258 (32.6)</td>
<td align="center" colspan="1" rowspan="1">184 (29.4)</td>
<td align="center" colspan="1" rowspan="1">0.87 (0.69-1.09)</td>
<td align="center" colspan="1" rowspan="1">0.211</td>
<td align="center" colspan="1" rowspan="1">0.396</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dominant (AA+GA vs. GG)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.88 (0.65-1.18)</td>
<td align="center" colspan="1" rowspan="1">0.394</td>
<td align="center" colspan="1" rowspan="1">0.537</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Recessive (AA vs. GA+GG)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.70 (0.42-1.18)</td>
<td align="center" colspan="1" rowspan="1">0.184</td>
<td align="center" colspan="1" rowspan="1">0.394</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs881827</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GG</td>
<td align="center" colspan="1" rowspan="1">157 (39.6)</td>
<td align="center" colspan="1" rowspan="1">127 (40.5)</td>
<td align="center" colspan="1" rowspan="1">1.0 (Ref)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GA</td>
<td align="center" colspan="1" rowspan="1">171 (43.2)</td>
<td align="center" colspan="1" rowspan="1">142 (45.4)</td>
<td align="center" colspan="1" rowspan="1">1.04 (0.75-1.44)</td>
<td align="center" colspan="1" rowspan="1">0.813</td>
<td align="center" colspan="1" rowspan="1">0.871</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AA</td>
<td align="center" colspan="1" rowspan="1">68 (17.2)</td>
<td align="center" colspan="1" rowspan="1">44 (14.1)</td>
<td align="center" colspan="1" rowspan="1">0.82 (0.53-1.29)</td>
<td align="center" colspan="1" rowspan="1">0.389</td>
<td align="center" colspan="1" rowspan="1">0.537</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="center" colspan="1" rowspan="1">485 (61.2)</td>
<td align="center" colspan="1" rowspan="1">396 (63.3)</td>
<td align="center" colspan="1" rowspan="1">1.0 (Ref)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="center" colspan="1" rowspan="1">307 (38.8)</td>
<td align="center" colspan="1" rowspan="1">230 (36.7)</td>
<td align="center" colspan="1" rowspan="1">0.93 (0.75-1.16)</td>
<td align="center" colspan="1" rowspan="1">0.517</td>
<td align="center" colspan="1" rowspan="1">0.646</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dominant (AA+GA vs. GG)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.98 (0.72-1.33)</td>
<td align="center" colspan="1" rowspan="1">0.888</td>
<td align="center" colspan="1" rowspan="1">0.888</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Recessive (AA vs. GA+GG)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.81 (0.53-1.22)</td>
<td align="center" colspan="1" rowspan="1">0.303</td>
<td align="center" colspan="1" rowspan="1">0.505</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs1051169</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GG</td>
<td align="center" colspan="1" rowspan="1">158 (39.9)</td>
<td align="center" colspan="1" rowspan="1">95 (30.4)</td>
<td align="center" colspan="1" rowspan="1">1.0 (Ref)</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GC</td>
<td align="center" colspan="1" rowspan="1">170 (42.9)</td>
<td align="center" colspan="1" rowspan="1">139 (44.4)</td>
<td align="center" colspan="1" rowspan="1">1.37 (0.97-1.92)</td>
<td align="center" colspan="1" rowspan="1">0.072</td>
<td align="center" colspan="1" rowspan="1">0.216</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1">68 (17.2)</td>
<td align="center" colspan="1" rowspan="1">79 (25.2)</td>
<td align="center" colspan="1" rowspan="1">
<bold>1.99 (1.32-3.02)</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.001</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.015</bold>
<sup>*</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="center" colspan="1" rowspan="1">486 (61.4)</td>
<td align="center" colspan="1" rowspan="1">329 (52.6)</td>
<td align="center" colspan="1" rowspan="1">1.0 (Ref)</td>
<td align="center" colspan="1" rowspan="1">
<bold>-</bold>
</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="center" colspan="1" rowspan="1">306 (38.6)</td>
<td align="center" colspan="1" rowspan="1">297 (47.4)</td>
<td align="center" colspan="1" rowspan="1">
<bold>1.46 (1.18-1.80)</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.001</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.015</bold>
<sup>*</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dominant (CC+GC vs. GG)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">
<bold>1.54 (1.13-2.11)</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.007</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.026</bold>
<sup>*</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Recessive (CC vs. GC+GG)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">
<bold>1.67 (1.16-2.42)</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.006</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.026</bold>
<sup>*</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>Boldface indicates significantly different. Ref: reference; OR: odds
ratio; 95% CI: 95% confidence interval. *: adjusted by age and gender.
<italic>P</italic><sub>BH</sub>: <italic>P</italic> values corrected by Benjamin-Hochberg
(B-H) method. <italic>P</italic><sub>BH</sub><sup>*</sup> remains significant after FDR test is applied.</attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Analysis of haplotype distribution between SLE patients and controls</title>
<p>The haplotypes frequencies of the three SNPs in S100B gene among the cases and
controls were also estimated in our study. It was performed online using the
SHEsis software, and the possible eight haplotypes are listed in <xref ref-type="table" rid="t3">Table 3</xref>. G-G-G and G-G-C were the two major
haplotypes, accounting for 27.7% and 20.3%, and 30.2% and 14.5% in both SLE
patients and controls, respectively. Moreover, we found the G-G-C haplotype to
be associated with an increased risk of SLE compared with controls (OR=1.50, 95%
CI, 1.14-1.98, <italic>p</italic>=0.004).</p>
<table-wrap id="t3" orientation="portrait" position="float">
<label>Table 3</label>
<caption>
<title>Haplotype distribution in the patients with SLE and the
controls.</title>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1" width="20%">
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr>
<th align="left" colspan="1" rowspan="1">Haplotype</th>
<th align="center" colspan="1" rowspan="1">Controls (2n=792)</th>
<th align="center" colspan="1" rowspan="1">SLE patients (2n=626)</th>
<th align="center" colspan="1" rowspan="1">OR (95% CI)</th>
<th align="center" colspan="1" rowspan="1">
<italic>p</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">A A C</td>
<td align="center" colspan="1" rowspan="1">57 (7.2)</td>
<td align="center" colspan="1" rowspan="1">49 (7.9)</td>
<td align="center" colspan="1" rowspan="1">1.11 (0.75-1.65)</td>
<td align="center" colspan="1" rowspan="1">0.608</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">A A G</td>
<td align="center" colspan="1" rowspan="1">71 (8.9)</td>
<td align="center" colspan="1" rowspan="1">39 (6.2)</td>
<td align="center" colspan="1" rowspan="1">0.68 (0.45-1.02)</td>
<td align="center" colspan="1" rowspan="1">0.060</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">A G C</td>
<td align="center" colspan="1" rowspan="1">72 (9.1)</td>
<td align="center" colspan="1" rowspan="1">63 (10.0)</td>
<td align="center" colspan="1" rowspan="1">1.12 (0.78-1. 59)</td>
<td align="center" colspan="1" rowspan="1">0.545</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">A G G</td>
<td align="center" colspan="1" rowspan="1">59 (7.4)</td>
<td align="center" colspan="1" rowspan="1">33 (5.2)</td>
<td align="center" colspan="1" rowspan="1">0.69 (0.44-1.07)</td>
<td align="center" colspan="1" rowspan="1">0.098</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">G A C</td>
<td align="center" colspan="1" rowspan="1">62 (7.8)</td>
<td align="center" colspan="1" rowspan="1">57 (9.2)</td>
<td align="center" colspan="1" rowspan="1">1.19 (0.82-1.73)</td>
<td align="center" colspan="1" rowspan="1">0.370</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">G A G</td>
<td align="center" colspan="1" rowspan="1">117 (14.8)</td>
<td align="center" colspan="1" rowspan="1">84 (13.4)</td>
<td align="center" colspan="1" rowspan="1">0.89 (0.66-1.21)</td>
<td align="center" colspan="1" rowspan="1">0.457</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">G G C</td>
<td align="center" colspan="1" rowspan="1">115 (14.5)</td>
<td align="center" colspan="1" rowspan="1">127 (20.3)</td>
<td align="center" colspan="1" rowspan="1">
<bold>1.50 (1.14-1.98)</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.004</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">G G G</td>
<td align="center" colspan="1" rowspan="1">239 (30.2)</td>
<td align="center" colspan="1" rowspan="1">173 (27.7)</td>
<td align="center" colspan="1" rowspan="1">0.88 (0.70-1.11)</td>
<td align="center" colspan="1" rowspan="1">0.291</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>Boldface indicates significantly different. OR: odds ratio; 95% CI:
95% confidence interval.</attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Association of rs1051169 polymorphisms with clinical features</title>
<p>We further performed a stratification analysis by comparing the distribution of
genotype and allele frequencies in rs1051169 between positive and negative
patients in 13 specific clinical features. Significant differences were observed
between the rs1051169 polymorphism and neurologic disorder
(<italic>p</italic>=0.013, <italic>p</italic>=0.003, respectively) (<xref ref-type="table" rid="t4">Table 4</xref>). In addition, patients in the case
group were further divided into two groups, which were the neurologic disorder
(ND) group and non-neurologic disorder (NND) group. When we further estimated
the rs1051169 polymorphism and the risk of neurologic disorder, we found the
rs1051169 C allele, GC genotype, CC genotype and dominant model to be associated
with increased susceptibility to neurologic disorder in SLE patients (C vs. G:
OR=1.78, 95% CI, 1.22-2.59, <italic>p</italic>=0.003; GC vs. GG: OR=2.33, 95%
CI, 1.14-4.77, <italic>p</italic>=0.019; CC vs. GG: OR=3.02, 95% CI, 1.39-6.53,
<italic>p</italic>=0.004; CC+GC vs. GG: OR=2.57, 95% CI=1.31-5.04,
<italic>p</italic>=0.005) (<xref ref-type="table" rid="t5">Table
5</xref>).</p>
<table-wrap id="t4" orientation="portrait" position="float">
<label>Table 4</label>
<caption>
<title>Association analysis of rs1051169 polymorphism with clinical
features.</title>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1" width="11%">
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr>
<th align="left" colspan="1" rowspan="1">Variables</th>
<th align="center" colspan="1" rowspan="1">+/-</th>
<th align="center" colspan="3" rowspan="1" style="border-bottom: thin solid; border-bottom: thin solid; border-color: #000000">Genotypes</th>
<th align="center" colspan="1" rowspan="1">
<italic>p</italic>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid; border-bottom: thin solid; border-color: #000000">Allele</th>
<th align="center" colspan="1" rowspan="1">
<italic>p</italic>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1">GG</th>
<th align="center" colspan="1" rowspan="1">CG</th>
<th align="center" colspan="1" rowspan="1">CC</th>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1">G</th>
<th align="center" colspan="1" rowspan="1">C</th>
<th colspan="1" rowspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Cutaneous vasculitis</td>
<td align="center" colspan="1" rowspan="1">+</td>
<td align="center" colspan="1" rowspan="1">52 (31.7)</td>
<td align="center" colspan="1" rowspan="1">75 (45.7)</td>
<td align="center" colspan="1" rowspan="1">37 (22.6)</td>
<td align="center" colspan="1" rowspan="1">0.516</td>
<td align="center" colspan="1" rowspan="1">179 (54.6)</td>
<td align="center" colspan="1" rowspan="1">149 (45.4)</td>
<td align="center" colspan="1" rowspan="1">0.289</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">43 (28.9)</td>
<td align="center" colspan="1" rowspan="1">64 (43.0)</td>
<td align="center" colspan="1" rowspan="1">42 (28.2)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">150 (50.3)</td>
<td align="center" colspan="1" rowspan="1">148 (49.7)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Family history of SLE</td>
<td align="center" colspan="1" rowspan="1">+</td>
<td align="center" colspan="1" rowspan="1">25 (28.1)</td>
<td align="center" colspan="1" rowspan="1">36 (40.4)</td>
<td align="center" colspan="1" rowspan="1">28 (31.5)</td>
<td align="center" colspan="1" rowspan="1">0.279</td>
<td align="center" colspan="1" rowspan="1">86 (48.3)</td>
<td align="center" colspan="1" rowspan="1">92 (51.7)</td>
<td align="center" colspan="1" rowspan="1">0.180</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">70 (31.3)</td>
<td align="center" colspan="1" rowspan="1">103 (46.0)</td>
<td align="center" colspan="1" rowspan="1">51 (22.7)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">243 (54.2)</td>
<td align="center" colspan="1" rowspan="1">205 (45.8)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Arthritis</td>
<td align="center" colspan="1" rowspan="1">+</td>
<td align="center" colspan="1" rowspan="1">47 (33.8)</td>
<td align="center" colspan="1" rowspan="1">62 (44.6)</td>
<td align="center" colspan="1" rowspan="1">30 (21.6)</td>
<td align="center" colspan="1" rowspan="1">0.314</td>
<td align="center" colspan="1" rowspan="1">156 (56.1)</td>
<td align="center" colspan="1" rowspan="1">122 (43.9)</td>
<td align="center" colspan="1" rowspan="1">0.111</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">48 (27.6)</td>
<td align="center" colspan="1" rowspan="1">77 (44.2)</td>
<td align="center" colspan="1" rowspan="1">49 (28.2)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">173 (49.7)</td>
<td align="center" colspan="1" rowspan="1">175 (50.3)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pleuritis</td>
<td align="center" colspan="1" rowspan="1">+</td>
<td align="center" colspan="1" rowspan="1">15 (35.7)</td>
<td align="center" colspan="1" rowspan="1">20 (47.6)</td>
<td align="center" colspan="1" rowspan="1">7 (16.7)</td>
<td align="center" colspan="1" rowspan="1">0.371</td>
<td align="center" colspan="1" rowspan="1">50 (59.5)</td>
<td align="center" colspan="1" rowspan="1">34 (40.5)</td>
<td align="center" colspan="1" rowspan="1">0.169</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">80 (29.5)</td>
<td align="center" colspan="1" rowspan="1">119 (43.9)</td>
<td align="center" colspan="1" rowspan="1">72 (26.6)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">279 (51.5)</td>
<td align="center" colspan="1" rowspan="1">263 (48.5)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Malar rash</td>
<td align="center" colspan="1" rowspan="1">+</td>
<td align="center" colspan="1" rowspan="1">31 (33.3)</td>
<td align="center" colspan="1" rowspan="1">42 (45.2)</td>
<td align="center" colspan="1" rowspan="1">20 (21.5)</td>
<td align="center" colspan="1" rowspan="1">0.567</td>
<td align="center" colspan="1" rowspan="1">104 (55.9)</td>
<td align="center" colspan="1" rowspan="1">82 (44.1)</td>
<td align="center" colspan="1" rowspan="1">0.274</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">64 (29.1)</td>
<td align="center" colspan="1" rowspan="1">97 (44.1)</td>
<td align="center" colspan="1" rowspan="1">59 (26.8)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">225 (51.1)</td>
<td align="center" colspan="1" rowspan="1">215 (48.9)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Renal disorder</td>
<td align="center" colspan="1" rowspan="1">+</td>
<td align="center" colspan="1" rowspan="1">48 (29.8)</td>
<td align="center" colspan="1" rowspan="1">78 (48.4)</td>
<td align="center" colspan="1" rowspan="1">35 (21.7)</td>
<td align="center" colspan="1" rowspan="1">0.239</td>
<td align="center" colspan="1" rowspan="1">174 (54.0)</td>
<td align="center" colspan="1" rowspan="1">148 (46.0)</td>
<td align="center" colspan="1" rowspan="1">0.445</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">47 (30.9)</td>
<td align="center" colspan="1" rowspan="1">61 (40.1)</td>
<td align="center" colspan="1" rowspan="1">44 (28.9)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">155 (51.0)</td>
<td align="center" colspan="1" rowspan="1">149 (49.0)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Neurologic disorder</td>
<td align="center" colspan="1" rowspan="1">+</td>
<td align="center" colspan="1" rowspan="1">12 (16.9)</td>
<td align="center" colspan="1" rowspan="1">35 (49.3)</td>
<td align="center" colspan="1" rowspan="1">24 (33.8)</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.013</bold>
</td>
<td align="center" colspan="1" rowspan="1">59 (41.5)</td>
<td align="center" colspan="1" rowspan="1">83 (58.5)</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.003</bold>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">83 (34.3)</td>
<td align="center" colspan="1" rowspan="1">104 (43.0)</td>
<td align="center" colspan="1" rowspan="1">55 (22.7)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">270 (55.8)</td>
<td align="center" colspan="1" rowspan="1">214(44.2)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-dsDNA</td>
<td align="center" colspan="1" rowspan="1">+</td>
<td align="center" colspan="1" rowspan="1">50 (32.7)</td>
<td align="center" colspan="1" rowspan="1">61 (39.9)</td>
<td align="center" colspan="1" rowspan="1">42 (27.5)</td>
<td align="center" colspan="1" rowspan="1">0.286</td>
<td align="center" colspan="1" rowspan="1">161 (52.6)</td>
<td align="center" colspan="1" rowspan="1">145 (47.4)</td>
<td align="center" colspan="1" rowspan="1">0.977</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">45 (28.1)</td>
<td align="center" colspan="1" rowspan="1">78 (48.8)</td>
<td align="center" colspan="1" rowspan="1">37 (23.1)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">168 (52.5)</td>
<td align="center" colspan="1" rowspan="1">152 (47.5)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-Sm</td>
<td align="center" colspan="1" rowspan="1">+</td>
<td align="center" colspan="1" rowspan="1">30 (24.4)</td>
<td align="center" colspan="1" rowspan="1">62 (50.4)</td>
<td align="center" colspan="1" rowspan="1">31 (25.2)</td>
<td align="center" colspan="1" rowspan="1">0.134</td>
<td align="center" colspan="1" rowspan="1">122 (49.6)</td>
<td align="center" colspan="1" rowspan="1">124 (50.4)</td>
<td align="center" colspan="1" rowspan="1">0.232</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">65 (34.2)</td>
<td align="center" colspan="1" rowspan="1">77 (40.5)</td>
<td align="center" colspan="1" rowspan="1">48 (25.3)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">207 (54.5)</td>
<td align="center" colspan="1" rowspan="1">173 (45.5)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-RNP</td>
<td align="center" colspan="1" rowspan="1">+</td>
<td align="center" colspan="1" rowspan="1">46 (34.1)</td>
<td align="center" colspan="1" rowspan="1">62 (45.9)</td>
<td align="center" colspan="1" rowspan="1">27 (20.0)</td>
<td align="center" colspan="1" rowspan="1">0.331</td>
<td align="center" colspan="1" rowspan="1">154 (57.0)</td>
<td align="center" colspan="1" rowspan="1">116 (43.0)</td>
<td align="center" colspan="1" rowspan="1">0.142</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">52 (29.2)</td>
<td align="center" colspan="1" rowspan="1">78 (43.8)</td>
<td align="center" colspan="1" rowspan="1">48 (27.0)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">182 (51.1)</td>
<td align="center" colspan="1" rowspan="1">174 (48.9)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ANA</td>
<td align="center" colspan="1" rowspan="1">+</td>
<td align="center" colspan="1" rowspan="1">88 (30.8)</td>
<td align="center" colspan="1" rowspan="1">130 (45.5)</td>
<td align="center" colspan="1" rowspan="1">68 (23.8)</td>
<td align="center" colspan="1" rowspan="1">0.148</td>
<td align="center" colspan="1" rowspan="1">306 (53.5)</td>
<td align="center" colspan="1" rowspan="1">266 (46.5)</td>
<td align="center" colspan="1" rowspan="1">0.125</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">7 (25.9)</td>
<td align="center" colspan="1" rowspan="1">9 (33.3)</td>
<td align="center" colspan="1" rowspan="1">11 (40.7)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">23 (42.6)</td>
<td align="center" colspan="1" rowspan="1">31 (57.4)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Low levels of C3</td>
<td align="center" colspan="1" rowspan="1">+</td>
<td align="center" colspan="1" rowspan="1">36 (28.3)</td>
<td align="center" colspan="1" rowspan="1">65 (51.2)</td>
<td align="center" colspan="1" rowspan="1">26 (20.5)</td>
<td align="center" colspan="1" rowspan="1">0.110</td>
<td align="center" colspan="1" rowspan="1">137 (53.9)</td>
<td align="center" colspan="1" rowspan="1">117 (46.1)</td>
<td align="center" colspan="1" rowspan="1">0.567</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">59 (31.7)</td>
<td align="center" colspan="1" rowspan="1">74 (39.8)</td>
<td align="center" colspan="1" rowspan="1">53 (28.5)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">192 (51.6)</td>
<td align="center" colspan="1" rowspan="1">180 (48.4)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Low levels of C4</td>
<td align="center" colspan="1" rowspan="1">+</td>
<td align="center" colspan="1" rowspan="1">27 (26.7)</td>
<td align="center" colspan="1" rowspan="1">53 (52.5)</td>
<td align="center" colspan="1" rowspan="1">21 (20.8)</td>
<td align="center" colspan="1" rowspan="1">0.136</td>
<td align="center" colspan="1" rowspan="1">107 (53.0)</td>
<td align="center" colspan="1" rowspan="1">95 (47.0)</td>
<td align="center" colspan="1" rowspan="1">0.886</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">68 (32.1)</td>
<td align="center" colspan="1" rowspan="1">86 (40.6)</td>
<td align="center" colspan="1" rowspan="1">58 (27.4)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">222 (52.4)</td>
<td align="center" colspan="1" rowspan="1">202 (47.6)</td>
<td colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>Boldface indicates significantly different. +: positive; -:
negative.</attrib>
</table-wrap-foot>
</table-wrap>
<table-wrap id="t5" orientation="portrait" position="float">
<label>Table 5</label>
<caption>
<title>Association of rs1051169 polymorphism with neurologic disorder
risk.</title>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1" width="16%">
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
<col span="1"/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr>
<th align="left" colspan="1" rowspan="1">Group</th>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1">+ (n=71)</th>
<th align="center" colspan="1" rowspan="1">- (n=242)</th>
<th align="center" colspan="1" rowspan="1">OR (95% CI)</th>
<th align="center" colspan="1" rowspan="1">
<italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Genotype</td>
<td align="center" colspan="1" rowspan="1">GG</td>
<td align="center" colspan="1" rowspan="1">12 (16.9)</td>
<td align="center" colspan="1" rowspan="1">83 (34.3)</td>
<td align="center" colspan="1" rowspan="1">1.0 (Ref)</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">GC</td>
<td align="center" colspan="1" rowspan="1">35 (49.3)</td>
<td align="center" colspan="1" rowspan="1">104 (43.0)</td>
<td align="center" colspan="1" rowspan="1">
<bold>2.33 (1.14-4.77)</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.019</bold>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1">24 (33.8)</td>
<td align="center" colspan="1" rowspan="1">55 (22.7)</td>
<td align="center" colspan="1" rowspan="1">
<bold>3.02 (1.39-6.53)</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.004</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Allele</td>
<td align="center" colspan="1" rowspan="1">G</td>
<td align="center" colspan="1" rowspan="1">59 (41.5)</td>
<td align="center" colspan="1" rowspan="1">270 (55.8)</td>
<td align="center" colspan="1" rowspan="1">1.0 (Ref)</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">C</td>
<td align="center" colspan="1" rowspan="1">83 (58.5)</td>
<td align="center" colspan="1" rowspan="1">214 (44.2)</td>
<td align="center" colspan="1" rowspan="1">
<bold>1.78 (1.22-2.59)</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.003</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dominant</td>
<td align="center" colspan="1" rowspan="1">GG</td>
<td align="center" colspan="1" rowspan="1">12 (16.9)</td>
<td align="center" colspan="1" rowspan="1">83 (34.3)</td>
<td align="center" colspan="1" rowspan="1">1.0 (Ref)</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">GC+CC</td>
<td align="center" colspan="1" rowspan="1">59 (83.1)</td>
<td align="center" colspan="1" rowspan="1">159 (65.7)</td>
<td align="center" colspan="1" rowspan="1">
<bold>2.57 (1.31-5.04)</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.005</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Recessive</td>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1">24 (33.8)</td>
<td align="center" colspan="1" rowspan="1">55 (22.7)</td>
<td align="center" colspan="1" rowspan="1">1.0 (Ref)</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">GG+GC</td>
<td align="center" colspan="1" rowspan="1">47 (66.2)</td>
<td align="center" colspan="1" rowspan="1">187 (77.3)</td>
<td align="center" colspan="1" rowspan="1">1.74 (0.98-3.09)</td>
<td align="center" colspan="1" rowspan="1">0.059</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Association between S100B polymorphisms and serum S100B levels</title>
<p>We also investigated the association between S100B polymorphisms and serum S100B
levels. We found that the serum S100B levels in SLE patients with neurologic
disorder were significantly higher than in non-neurologic disorder patients and
controls (<italic>p</italic> &lt; 0.05, respectively) (<xref ref-type="fig" rid="f1">Figure 1A</xref>). Considering that the rs1051169 polymorphism may
play an important role in the etiology of SLE, especially in the patients with
neurologic disorder, we then performed a comparison between rs1051169 genotypes
and serum S100B levels, and observed that the patients with neurologic disorder
carrying the rs1051169 CC/GC genotypes presented higher serum S100B levels
compared with those carrying the rs1051169 GG genotype (both <italic>p</italic>
&lt; 0.05) (<xref ref-type="fig" rid="f1">Figure 1B</xref>).</p>
<fig id="f1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<title>ELISA detection of S100B levels. (A) The SLE patients with neurologic
disorder (125.08 ± 20.34 pg/mL, n=71) showed higher serum S100B levels
than non-neurologic disorder patients (112.30 ± 27.98 pg/mL, n=71) and
controls (97.16 ± 20.34 pg/mL, n=71), respectively [both
<italic>p</italic> &lt; 0.05]. (ND-neurologic disorder). (B) The SLE
patients with neurologic disorder carrying the rs1051169 CC genotype
(140.29 ± 28.17 pg/mL, n=24) showed significantly higher serum S100B
levels than whose with GC (122.47 ± 24.11 pg/mL, n=35) and GG genotype
(102.24 ± 18.26 pg/mL, n=12), respectively (both <italic>p</italic> &lt;
0.05).</title>
</caption>
<graphic xlink:href="1415-4757-GMB-1678-4685-GMB-2017-0354-gf01"></graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>In this study, we investigated the association between three SNPs in the S100B gene
and SLE risk in a Chinese population. We found that the rs1051169 C allele, CC
genotype, dominant model (CC+GC vs. GG) and recessive model (CC vs. GC+GG) were
significantly associated with increased risk of SLE. Haplotype analysis showed that
the G-G-C haplotype was associated with an increased risk of SLE. Moreover, further
stratified analyses showed that SLE patients carrying the rs1051169 C allele, GC
genotype, CC genotype and dominant model (CC+GC vs. GG) were more likely to develop
neurologic disorder. In addition, we observed that in individuals carrying rs1051169
CC genotype there was an association with abnormal expression of S100B in SLE
patients with neurologic disorder. Taken together, these findings indicate that the
S100B gene rs1051169 polymorphism may play a critical role in the etiology of SLE,
especially in patients with neurologic disorder.</p>
<p>The synonymous variant SNP rs1051169 is located in the promoter region of the S100B
gene, and several studies have reported an association between the rs1051169
polymorphism and human diseases, however, the results were inconsistent. <xref ref-type="bibr" rid="B44">Zhai <italic>et al.</italic> (2011)</xref> found that
the rs1051169 variant was correlated with schizophrenia patients’ poorer spatial
ability in a Chinese population. Similarly, a case-control study conducted by <xref ref-type="bibr" rid="B23">Liu <italic>et al.</italic> (2005)</xref> reported
that the rs1051169 GG genotype was associated with an increased risk of
schizophrenia in a Chinese population. However, <xref ref-type="bibr" rid="B14">Guo
<italic>et al.</italic> (2013)</xref> have tried to detect an association of
the rs1051169 polymorphism with Parkinson’s disease in a Chinese population, but
failed to obtain a positive result. In this study, our findings were in agreement
with the positive results of <xref ref-type="bibr" rid="B44">Zhai <italic>et
al.</italic> (2011)</xref> and <xref ref-type="bibr" rid="B23">Liu
<italic>et al.</italic> (2005)</xref>, as we found that the rs1051169 C
allele, CC genotype, CC+GC vs. GG and CC vs. GC+GG had 1.46-fold, 1.99-fold,
1.54-fold and 1.67-fold increased risks of developing SLE, respectively.
Furthermore, a stratified analysis showed that the rs1051169 C allele, GC genotype,
CC genotype, and CC vs. GC+GG were associated with increased susceptibility to
neurologic disorder in SLE patients. In addition, the SLE patients with neurologic
disorder carrying CC or CG genotypes seem to exhibit relatively higher levels of
expression S100B compared with those carrying the GG genotype. It is known that
polymorphisms in the promoter region of certain genes might regulate their
expression by altering the binding sites of transcription factors (<xref ref-type="bibr" rid="B32">Sun, <italic>et al.</italic>, 2007</xref>; <xref ref-type="bibr" rid="B28">Shao, <italic>et al.</italic>, 2017</xref>). We
hypothesized that the synonymous SNP rs1051169 located in the exon of S100B may
exert an influence on splicing, thereby affecting the levels of serum S100B, which
ultimately potentiate S100B-mediated pro-inflammatory processes, increase SLE risk,
and promote neurologic disorder development.</p>
<p>With regard to rs9722 and disease risk, contradictory results were also observed.
<xref ref-type="bibr" rid="B24">Matsson <italic>et al.</italic> (2015)</xref>
reported that the rs9722 T allele was associated with dyslexia in a German family.
In a case-control study, <xref ref-type="bibr" rid="B21">Li <italic>et al.</italic>
(2017)</xref> demonstrated that the rs9722 T allele was significantly associated
with the risk of severehand, foot, and mouth disease. A positive result was also
observed in schizophrenia patients (<xref ref-type="bibr" rid="B44">Zhai, <italic>et
al.</italic>, 2011</xref>). However, <xref ref-type="bibr" rid="B40">Yang K
<italic>et al.</italic> (2008)</xref> showed that the rs9722 polymorphism
was not correlated with the risk of major depressive disorder in a Chinese
population. Our results are in concordance with the negative result of <xref ref-type="bibr" rid="B40">Yang K <italic>et al.</italic> (2008)</xref>. Several
possibilities need to be taken into account to explain the negative results.
Firstly, genetic polymorphisms play different roles in different diseases,
especially in diverse ethnicities. Furthermore, we cannot rule out the possibility
that the negative result is due to the relatively small number of subjects.
Regarding the rs881827 polymorphism, up to now, a very limited number of studies has
assessed the association of rs881827 polymorphism with human disease susceptibility.
In our study, no association of rs881827 SNP with SLE risk was observed.</p>
<p>SLE is a complex chronic inflammatory disease. Although the exact mechanisms
responsible for initiating SLE remain unclear, it is well known that inflammatory
cytokines play an important and diverse role in the pathogenesis of SLE. S100B is a
multigene family of small (-10 kDa) Ca<sup>2+</sup> binding proteins, which can
combine with RAGE to induce the secretion of a variety of thepro-inflammatory
cytokines, such as TNF-α, IL-1β, IL-6, and IL-8 (<xref ref-type="bibr" rid="B4">Bianchi, <italic>et al.</italic>, 2010</xref>; <xref ref-type="bibr" rid="B7">Dang, <italic>et al.</italic>, 2014</xref>; <xref ref-type="bibr" rid="B26">Niven, <italic>et al.</italic>, 2015</xref>). Several studies have demonstrated
that these inflammatory cytokines play crucial roles in the pathogenic process of
SLE (<xref ref-type="bibr" rid="B31">Sun, <italic>et al.</italic>, 2000</xref>;
<xref ref-type="bibr" rid="B43">Ye, <italic>et al.</italic>, 2014</xref>).
Besides, previous study showed that serum TNF-α, IL-1β, IL-6, and IL-8 levels in
central nervous system neuropsychiatric SLE (CNS-NPSLE) cases were higher than those
in the control and non-CNS SLE groups (<xref ref-type="bibr" rid="B37">Wang,
<italic>et al.</italic>, 2015</xref>). Moreover, higher serum S100B levels
have been reported to reflect brain injury and increased permeability of the
blood–brain barrier (BBB) (<xref ref-type="bibr" rid="B41">Yang XY <italic>et
al.</italic>, 2008</xref>;<xref ref-type="bibr" rid="B12"> Fragoso-Loyo,
<italic>et al.</italic>, 2010</xref>). In our study, we observed that serum
S100B levels in SLE patients with neurologic disorder were significantly higher than
in non-neurologic disorder patients and controls. Based on this background, the
positive results in our study were biologically reasonable.</p>
<p>Although the current study showed that S100B polymorphisms may play a critical role
in the etiology of SLE, our study also has the following limitations. Firstly, the
relatively small sample size may have limited the statistical power in our study.
Secondly, all participants were recruited from the same hospital, so the possibility
of selection bias cannot be ruled out. Thirdly, due to the lack of complete clinical
data we cannot assess the impact of medical regimens on the results of this study.
Another limitation is that data on environmental exposure is not available, which
prevented further analysis of the effect of a gene–environment interaction on SLE
risk. Therefore, further studies with larger sample sizes and including
gene-environment interaction are warranted.</p>
</sec>
<sec sec-type="conclusions">
<title>Conclusions</title>
<p>Our results indicate that the S100B gene rs1051169 polymorphism may play a major role
in the pathogenesis and development of SLE. Further studies with larger samples and
in different populations are needed to confirm these findings.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This work was supported by the National Natural Science Foundation of China (No.
81560552; No. 81260234) and the Innovation project of Guangxi Graduate Education
(NO. YCSW2017213).</p>
</ack>
<fn-group>
<fn fn-type="other" id="fn1">
<p>
<italic>Associate Editor: Regina C. Mingroni-Netto</italic>
</p>
</fn>
</fn-group>
<sec>
<title>Conflict of interest</title>
<p>The authors declare no conflict of interests.</p>
</sec>
<sec>
<title>Author contributions</title>
<p>YLL, YSW and YL conceived and designed the study; YLL, HTH, RW and CHL conducted the
experiments; YLL, HTH, YLZ and CFW analyzed the data; YLL, CHL and HTH wrote the
manuscript. All authors read and approved the final version.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alarcon-Segovia</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Alarcon-Riquelme</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Cardiel</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Caeiro</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Massardo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Villa</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Pons-Estel</surname>
<given-names>BA</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Familial aggregation of systemic lupus erythematosus, rheumatoid
arthritis, and other autoimmune diseases in 1,177 lupus patients from the
GLADEL cohort</article-title>
<source/>Arthritis Rheumatism
          <volume>52</volume>
<fpage>1138</fpage>
<lpage>1147</lpage>
<pub-id pub-id-type="pmid">15818688</pub-id>
</element-citation>
</ref>
<ref id="B2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aringer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dorner</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Leuchten</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>SR</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Toward new criteria for systemic lupus erythematosus - a
standpoint</article-title>
<source/>Lupus
          <volume>25</volume>
<fpage>805</fpage>
<lpage>811</lpage>
<pub-id pub-id-type="pmid">27252256</pub-id>
</element-citation>
</ref>
<ref id="B3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bechmann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Madsen</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Brandslund</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Ormstrup</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jakobsen</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Jylling</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Steffensen</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Jakobsen</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Predicting brain metastases of breast cancer based on serum S100B
and serum HER2</article-title>
<source/>Oncol Lett
          <volume>6</volume>
<fpage>1265</fpage>
<lpage>1270</lpage>
<pub-id pub-id-type="pmid">24179506</pub-id>
</element-citation>
</ref>
<ref id="B4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bianchi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Giambanco</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Donato</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>S100B/RAGE-dependent activation of microglia via NF-kappaB and
AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and
TNF-alpha</article-title>
<source/>Neurobiol Aging
          <volume>31</volume>
<fpage>665</fpage>
<lpage>677</lpage>
<pub-id pub-id-type="pmid">18599158</pub-id>
</element-citation>
</ref>
<ref id="B5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bianchi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kastrisianaki</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Giambanco</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Donato</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>S100B protein stimulates microglia migration via RAGE-dependent
up-regulation of chemokine expression and release</article-title>
<source/>J Biol Chem
          <volume>286</volume>
<fpage>7214</fpage>
<lpage>7226</lpage>
<pub-id pub-id-type="pmid">21209080</pub-id>
</element-citation>
</ref>
<ref id="B6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>LY</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>YM</given-names>
</name>
<etal></etal>
</person-group>
<year>2017</year>
<article-title>S100B promotes injury-induced vascular remodeling through
modulating smooth muscle phenotype</article-title>
<source/>Biochim Biophys Acta MOl Basis Dis
          <volume>1863</volume>
<fpage>2772</fpage>
<lpage>2783</lpage>
<pub-id pub-id-type="pmid">28693920</pub-id>
</element-citation>
</ref>
<ref id="B7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>S100B ranks as a new marker of multiple traumas in patients and
may accelerate its development by regulating endothelial cell
dysfunction</article-title>
<source/>Int J Clin Exp Pathol
          <volume>7</volume>
<fpage>3818</fpage>
<lpage>3826</lpage>
<pub-id pub-id-type="pmid">25120758</pub-id>
</element-citation>
</ref>
<ref id="B8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dix</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Czakai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Springer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fliesser</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bonin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Guthke</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Einsele</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Linde</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Loffler</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Genome-wide expression profiling reveals S100B as biomarker for
invasive Aspergillosis</article-title>
<source/>Front Microbiol
          <volume>7</volume>
<fpage>320</fpage>
<pub-id pub-id-type="pmid">27047454</pub-id>
</element-citation>
</ref>
<ref id="B9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donato</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sorci</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Riuzzi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Arcuri</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bianchi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Brozzi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tubaro</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Giambanco</surname>
<given-names>I</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>S100B’s double life: Intracellular regulator and extracellular
signal</article-title>
<source/>Biochim Biophys Acta
          <volume>1793</volume>
<fpage>1008</fpage>
<lpage>1022</lpage>
<pub-id pub-id-type="pmid">19110011</pub-id>
</element-citation>
</ref>
<ref id="B10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donato</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cannon</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Sorci</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Riuzzi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Geczy</surname>
<given-names>CL</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Functions of S100 proteins</article-title>
<source/>Curr Mol Med
          <volume>13</volume>
<fpage>24</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="pmid">22834835</pub-id>
</element-citation>
</ref>
<ref id="B11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egger</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Roetzer</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Noor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Mahmood</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Schwarzbraun</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Boright</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Mikhailov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Windpassinger</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<year>2014</year>
<article-title>Identification of risk genes for autism spectrum disorder through
copy number variation analysis in Austrian families</article-title>
<source/>Neurogenetics
          <volume>15</volume>
<fpage>117</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="pmid">24643514</pub-id>
</element-citation>
</ref>
<ref id="B12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fragoso-Loyo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cabiedes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Atisha-Fregoso</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Llorente</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sanchez-Guerrero</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Utility of serum S100B protein for identification of central
nervous system involvement in systemic lupus erythematosus</article-title>
<source/>J Rheumatol
          <volume>37</volume>
<fpage>2280</fpage>
<lpage>2285</lpage>
<pub-id pub-id-type="pmid">20716661</pub-id>
</element-citation>
</ref>
<ref id="B13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomez-Tourino</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Simon-Vazquez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Alonso-Lorenzo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Arif</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Calvino-Sampedro</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gonzalez-Fernandez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pena-Gonzalez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vinuela-Roldan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Verdaguer</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<year>2015</year>
<article-title>Characterization of the autoimmune response against the nerve
tissue S100beta in patients with type 1 diabetes</article-title>
<source/>Clin Exp Immunol
          <volume>180</volume>
<fpage>207</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="pmid">25516468</pub-id>
</element-citation>
</ref>
<ref id="B14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Genetic analysis of the S100B gene in Chinese patients with
Parkinson disease</article-title>
<source/>Neurosci Lett
          <volume>555</volume>
<fpage>134</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="pmid">24076007</pub-id>
</element-citation>
</ref>
<ref id="B15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hochberg</surname>
<given-names>MC</given-names>
</name>
</person-group>
<year>1997</year>
<article-title>Updating the American College of Rheumatology revised criteria
for the classification of systemic lupus erythematosus</article-title>
<source/>Arthritis Rheumatism
          <volume>40</volume>
<fpage>1725</fpage>
</element-citation>
</ref>
<ref id="B16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hofmann</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Drury</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Taguchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Avila</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kambham</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bierhaus</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nawroth</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<year>1999</year>
<article-title>RAGE mediates a novel proinflammatory axis: A central cell
surface receptor for S100/calgranulin polypeptides</article-title>
<source/>Cell
          <volume>97</volume>
<fpage>889</fpage>
<lpage>901</lpage>
<pub-id pub-id-type="pmid">10399917</pub-id>
</element-citation>
</ref>
<ref id="B17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hohoff</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ponath</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Freitag</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Kastner</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Krakowitzky</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Domschke</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Koelkebeck</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kipp</surname>
<given-names>F</given-names>
</name>
<name>
<surname>von Eiff</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Deckert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rothermundt</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Risk variants in the S100B gene predict elevated S100B serum
concentrations in healthy individuals</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <volume>153b</volume>
<fpage>291</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="pmid">19330775</pub-id>
</element-citation>
</ref>
<ref id="B18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holloway</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Humphrey</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Heron</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pilling</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kitchen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hojbjerre</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Strandberg-Larsen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>BB</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Patient-reported outcome measures for systemic lupus
erythematosus clinical trials: A review of content validity, face validity
and psychometric performance</article-title>
<source/>Health quality Life Outcomes
          <volume>12</volume>
<fpage>116</fpage>
</element-citation>
</ref>
<ref id="B19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>JY</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>S100B protein expressions as an independent predictor of early
relapse in UICC stages II and III colon cancer patients after curative
resection</article-title>
<source/>Ann Surg Oncol
          <volume>18</volume>
<fpage>139</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="pmid">20628824</pub-id>
</element-citation>
</ref>
<ref id="B20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lapa</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Postal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sinicato</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Bellini</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Marini</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Appenzeller</surname>
<given-names>S</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>S100beta is associated with cognitive impairment in
childhood-onset systemic lupus erythematosus patients</article-title>
<source/>Lupus
          <volume>26</volume>
<fpage>478</fpage>
<lpage>483</lpage>
<pub-id pub-id-type="pmid">28394234</pub-id>
</element-citation>
</ref>
<ref id="B21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>NY</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>ZZ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>WX</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>ZP</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Association between S100B gene polymorphisms and hand, foot and
mouth disease caused by enterovirus 71 infection</article-title>
<source/>Zhongguo Dang Dai Er Ke Za Zhi.
          <volume>19</volume>
<fpage>904</fpage>
<lpage>907</lpage>
<pub-id pub-id-type="pmid">28774366</pub-id>
</element-citation>
</ref>
<ref id="B22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>XW</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<year>2012</year>
<article-title>Epidemiology of eight common rheumatic diseases in China: A
large-scale cross-sectional survey in Beijing</article-title>
<source/>Rheumatology
          <volume>51</volume>
<fpage>721</fpage>
<lpage>729</lpage>
<pub-id pub-id-type="pmid">22179737</pub-id>
</element-citation>
</ref>
<ref id="B23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>He</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<year>2005</year>
<article-title>SNPs and haplotypes in the S100B gene reveal association with
schizophrenia</article-title>
<source/>Biochem Biophys Res Commun
          <volume>328</volume>
<fpage>335</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="pmid">15670788</pub-id>
</element-citation>
</ref>
<ref id="B24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Huss</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Persson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Einarsdottir</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tiraboschi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nopola-Hemmi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Neuhoff</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Warnke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lyytinen</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<year>2015</year>
<article-title>Polymorphisms in DCDC2 and S100B associate with developmental
dyslexia</article-title>
<source/>J Hum Genet
          <volume>60</volume>
<fpage>399</fpage>
<lpage>401</lpage>
<pub-id pub-id-type="pmid">25877001</pub-id>
</element-citation>
</ref>
<ref id="B25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gion</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mukae</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yoshino</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Morphologic, flow cytometric, functional, and molecular analyses
of S100B positive lymphocytes, unique cytotoxic lymphocytes containing S100B
protein</article-title>
<source/>Eur J Haematol
          <volume>90</volume>
<fpage>99</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="pmid">23130680</pub-id>
</element-citation>
</ref>
<ref id="B26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niven</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hoare</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McGowan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Devarajan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Itohara</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gannage</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Teismann</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Crane</surname>
<given-names>I</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>S100B Up-regulates macrophage production of IL1beta and CCL22 and
influences severity of retinal inflammation</article-title>
<source/>PLoS One
          <volume>10</volume>
<fpage>e0132688</fpage>
<pub-id pub-id-type="pmid">26204512</pub-id>
</element-citation>
</ref>
<ref id="B27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roche</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cassidy</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Badger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Claffey</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mooney</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Delaney</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dobrin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>McKeon</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Candidate gene analysis of 21q22: support for S100B as a
susceptibility gene for bipolar affective disorder with
psychosis</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <volume>144B</volume>
<fpage>1094</fpage>
<lpage>1096</lpage>
<pub-id pub-id-type="pmid">17525977</pub-id>
</element-citation>
</ref>
<ref id="B28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<year>2017</year>
<article-title>The promoter polymorphisms of receptor for advanced glycation end
products were associated with the susceptibility and progression of
sepsis</article-title>
<source/>Clin Genet
          <volume>91</volume>
<fpage>564</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="pmid">27172264</pub-id>
</element-citation>
</ref>
<ref id="B29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Aberrant low expression of A20 in Tumor Necrosis
Factor-alpha-stimulated SLE monocytes mediates sustained NF-kappaB
inflammatory response</article-title>
<source/>Immunol Invest
          <volume>44</volume>
<fpage>497</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="pmid">26107748</pub-id>
</element-citation>
</ref>
<ref id="B30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>SHEsis, a powerful software platform for analyses of linkage
disequilibrium, haplotype construction, and genetic association at
polymorphism loci</article-title>
<source/>Cell Res
          <volume>15</volume>
<fpage>97</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="pmid">15740637</pub-id>
</element-citation>
</ref>
<ref id="B31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>GH</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Monoclonal anti-double-stranded DNA autoantibody stimulates the
expression and release of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha from
normal human mononuclear cells involving in the lupus
pathogenesis</article-title>
<source/>Immunology
          <volume>99</volume>
<fpage>352</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="pmid">10712664</pub-id>
</element-citation>
</ref>
<ref id="B32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<etal></etal>
</person-group>
<year>2007</year>
<article-title>A six-nucleotide insertion-deletion polymorphism in the CASP8
promoter is associated with susceptibility to multiple
cancers</article-title>
<source/>Nat Genet
          <volume>39</volume>
<fpage>605</fpage>
<lpage>613</lpage>
<pub-id pub-id-type="pmid">17450141</pub-id>
</element-citation>
</ref>
<ref id="B33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiffin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Adeyemo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Okpechi</surname>
<given-names>I</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>A diverse array of genetic factors contribute to the pathogenesis
of systemic lupus erythematosus</article-title>
<source/>Orphanet J Rare Dis
          <volume>8</volume>
<fpage>2</fpage>
<pub-id pub-id-type="pmid">23289717</pub-id>
</element-citation>
</ref>
<ref id="B34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulff-Moller</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Simonsen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kyvik</surname>
<given-names>KO</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Frisch</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Family history of systemic lupus erythematosus and risk of
autoimmune disease: Nationwide Cohort Study in Denmark
1977-2013</article-title>
<source/>Rheumatology
          <volume>56</volume>
<fpage>957</fpage>
<lpage>964</lpage>
<pub-id pub-id-type="pmid">28339674</pub-id>
</element-citation>
</ref>
<ref id="B35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uspenskaya</surname>
<given-names>YA</given-names>
</name>
<name>
<surname>Komleva</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Pozhilenkova</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Salmin</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Lopatina</surname>
<given-names>OL</given-names>
</name>
<name>
<surname>Fursov</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Lavrentiev</surname>
<given-names>PV</given-names>
</name>
<name>
<surname>Belova</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Salmina</surname>
<given-names>AB</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Ligands of RAGE-proteins: Role in intercellular communication and
pathogenesis of inflammation</article-title>
<source/>Vestnik Rossiiskoi Akad Meditsin Nauk
          <volume>2015</volume>
<fpage>694</fpage>
<lpage>703</lpage>
</element-citation>
</ref>
<ref id="B36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wada</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Saeki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kuroda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Narita</surname>
<given-names>I</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Long-term prognosis and factors associated with damage accrual in
Japanese patients with systemic lupus erythematosus</article-title>
<source/>Clin Exp Nephrol
          <volume>22</volume>
<fpage>597</fpage>
<lpage>692</lpage>
<pub-id pub-id-type="pmid">29071504</pub-id>
</element-citation>
</ref>
<ref id="B37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Role of IL-1beta, IL-6, IL-8 and IFN-gamma in pathogenesis of
central nervous system neuropsychiatric systemic lupus
erythematous</article-title>
<source/>Int J Clin Exp Med
          <volume>8</volume>
<fpage>16658</fpage>
<lpage>16663</lpage>
<pub-id pub-id-type="pmid">26629199</pub-id>
</element-citation>
</ref>
<ref id="B38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>XK</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>YZ</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mix</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are
correlated with subtypes of Guillain-Barre syndrome</article-title>
<source/>Neurol Sci
          <volume>34</volume>
<fpage>655</fpage>
<lpage>661</lpage>
<pub-id pub-id-type="pmid">22526766</pub-id>
</element-citation>
</ref>
<ref id="B39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<year>2014</year>
<article-title>Correlation between cerebral microbleeds and S100B/RAGE in acute
lacunar stroke patients</article-title>
<source/>J Neurol Sci
          <volume>340</volume>
<fpage>208</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="pmid">24656601</pub-id>
</element-citation>
</ref>
<ref id="B40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>YQ</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>FQ</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>LY</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>No association of the rs9722 C &gt; T in the S100B gene and
susceptibility to major depression in a Chinese population</article-title>
<source/>Genet Testing
          <volume>12</volume>
<fpage>487</fpage>
<lpage>489</lpage>
</element-citation>
</ref>
<ref id="B41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>XY</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Expression of S100B protein levels in serum and cerebrospinal
fluid with different forms of neuropsychiatric systemic lupus
erythematosus</article-title>
<source/>Clin Rheumatol
          <volume>27</volume>
<fpage>353</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="pmid">17955279</pub-id>
</element-citation>
</ref>
<ref id="B42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yardan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Erenler</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Baydin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Aydin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cokluk</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Usefulness of S100B protein in neurological
disorders</article-title>
<source/>JPMA J Pakistan Med Assoc
          <volume>61</volume>
<fpage>276</fpage>
<lpage>281</lpage>
</element-citation>
</ref>
<ref id="B43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<year>2014</year>
<article-title>IL-37 inhibits the production of inflammatory cytokines in
peripheral blood mononuclear cells of patients with systemic lupus
erythematosus: Its correlation with disease activity</article-title>
<source/>J Transl Med
          <volume>12</volume>
<fpage>69</fpage>
<pub-id pub-id-type="pmid">24629023</pub-id>
</element-citation>
</ref>
<ref id="B44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<year>2011</year>
<article-title>Risk variants in the S100B gene, associated with elevated S100B
levels, are also associated with visuospatial disability of
schizophrenia</article-title>
<source/>Behav Brain Res
          <volume>217</volume>
<fpage>363</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="pmid">21070816</pub-id>
</element-citation>
</ref>
<ref id="B45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhi-Chun</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Qiao-Ling</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhi-Qin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xiao-Zhao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xiao-Xia</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Rong</surname>
<given-names>T</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Tumor necrosis factor-like weak inducer of apoptosis (TWEAK)
mediates p38 mitogen-activated protein kinase activation and signal
transduction in peripheral blood mononuclear cells from patients with lupus
nephritis</article-title>
<source/>Inflammation
          <volume>35</volume>
<fpage>935</fpage>
<lpage>943</lpage>
<pub-id pub-id-type="pmid">22009442</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>